BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1332992)

  • 1. [Low-molecular heparin complex formation with the blood coagulation proteins--thrombin and fibrinogen].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1992; (5):802-6. PubMed ID: 1332992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a complex mixture of plasma proteins with heparin on the anticoagulation and fibrinolytic activity of the blood plasma in animals following intravenous administration of tissue thromboplastin].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1988 Jun; 74(6):814-9. PubMed ID: 3181520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
    Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
    Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin-independent effects of heparins on fibrin clot nanostructure.
    Yeromonahos C; Marlu R; Polack B; Caton F
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1320-4. PubMed ID: 22362760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of inhibition of non-enzymatic fibrinolysis by a spleen factor].
    Liapina LA; Azieva LD
    Biokhimiia; 1985 Jan; 50(1):69-73. PubMed ID: 3978152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
    von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W; Koschinsky ML
    Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The blood anticoagulant system in rats perorally administered a heparin-acetylsalicylic acid complex].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1991; (4):625-30. PubMed ID: 1787232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
    Stief TW
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.
    Bendayan P; Boccalon H; Dupouy D; Boneu B
    Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Vopr Med Khim; 1978; 24(2):255-60. PubMed ID: 149422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complex compounds of heparin in obstetric hemorrhages].
    Kudrjashov BA; Bloshansky UM; Polol'skaya OV; Lyapina LA; Kaverina KP; Spoludennaya ST
    Vopr Med Khim; 1975; 21(5):531-8. PubMed ID: 1082678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin complex formation with plasma proteins in an analytic ultracentrifuge].
    Liapina LA; Zhitnikova ES; Boneva ZhS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (3):25-8. PubMed ID: 7074180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.